Seeking Alpha

Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60...

Ariad Pharmaceuticals (ARIA -2.4%) slips today after pricing its 15.3M share offering at $19.60 a share, a 1.3% discount to Wednesday's close. The company's float stands at around 166.3M shares. ARIA plans to use the proceeds for making and marketing its leukemia treatment Iclusig and for developing its other drug candidates.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|